Leveraging the experience of cord blood banking in the development of cellular therapies

This webinar will focus on how to utilize the expertise of cord blood banks when considering a source of allogeneic starting material for development of cellular therapies. Cord blood banks have decades of experience managing the development, production and distribution of allogeneic products in a regulated environment.

• Comprehend the benefits of cord blood as an allogeneic cell source in cellular therapy
• Discover how to gain access to therapy matched cord blood units
• Grasp the characteristics and attributes of the existing inventory of cord blood units and how they may relate to your therapy
• Learn the importance of managing logistics to deliver cord blood units from the bank to the cell therapy developer
• Join in the discussion to consider alternative banking and attribute models that may be needed in the future to support novel therapies

Heather Stefanski

Vice President, Medical Services, NMDP/Be The Match

Marcie Finney

Executive Director, Cleveland Cord Blood Center

Christina Melief

Business Development Program Manager, Bloodworks Bio

Ana Valverde

Administrative Director, Carolinas Cord Blood Bank